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1. Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x Tested and ƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
diĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
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screening programme. 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2. Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3. Population and Healthcare Overview 
The population of Bulgaria is estimated at 7,075,991 (World Bank, 2018a) and a birth rate 
estimated at 9.1 births/1,000 population in 2016 (World Bank, 2018b). The change in 
population and birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B 
respectively.  
In 2017 Bulgaria has a reported population density of 65.18 people per square kilometre 
and this has fallen from 71.79 people per square kilometre in 1961 (World Bank, 2018c). 
Infant mortality in 2017 is estimated at 6.3 deaths/1,000 live births in total (World Bank, 
2018d). 
The average life expectancy in Bulgaria is estimated at 74.6 (World Bank, 2018e), with a 
death rate of 15.1 deaths/1,000 population in 2016 (World Bank, 2018f). Bulgaria has a 
gross national income per capita (PPP int. $, 2013) of $15,000 (WHO, 2016). The estimated 
total expenditure on health per capita in 2014 was $1,399 (Intl $) and the total expenditure 
on health in 2014 as percentage of GDP was 8.4% (WHO, 2016). 
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Figure 1: Change in the Total Population and Birth Rate in Bulgaria between 1960 and 2017 
 
Source: Information sourced from World Bank (2018)   
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4. Vision Screening Commissioning and Guidance 
Vision screening is not set-up as a national programme in Bulgaria and is organised 
regionally. Dates that these regional services started and changes to services are not known. 
Vision screening is conducted as part of charity programmes in different cities and villages, 
among different age groups and usually in schools. There are no regions in Bulgaria that 
have a standardised vision screening programme, every charity campaigns are funded by 
different sources. There are no guidelines for vision screening available in Bulgaria. 
However, the Ministry of Health in Bulgaria have stated that GPs should perform a visual 
acuity assessment after the age of 3 years with vision screening embedded into a general 
preventative child healthcare screening programme.  
In Bulgaria, vision screening is performed by ophthalmologists, neonatologists and general 
practitioners (GP). It is not known how many vision screening professionals there are in 
Bulgaria, per million population. Not all GPs perform vision screening, and as such, there are 
some that could do so with additional training. Paediatricians and nurses are also healthcare 
professionals within the country who could deliver vision screening with additional training. 
Currently there is no specific training to perform vision screening.  
Coverage can differ between cities, schools and kindergartens and the tests used vary; some 
are using only automated screening, others test visual acuity and more. There are no 
methods for quality monitoring imposed by the government. There is only one reported 
paper published on the outcomes of vision screening (Dikova, Dragoev & Chernodrinska, 
2015); this does not include cost-effectiveness analysis. 
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5. Screening programme  
Target conditions for vision screening have not been identified as there is no protocol for 
vision screening in Bulgaria. The health care professionals delivering vision screening, venue 
for screening and tests used vary depending on the age of the child as shown in Tables 1, 2 
and 3 respectively. Specific details of the screening offered within each age group and 
within different regions are described more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
There is no national policy for preterm babies. In the capital cities of Sofia and Plovdiv, a few 
hospitals screen for retinopathy of prematurity (ROP) by a paediatric ophthalmologist in a 
hospital. There are RetCams in Sofia, Varne and Ruse. Parents can travel to Sofia or Plovdiv, 
if they live in other areas, otherwise no vision screening is conducted. The vision screening 
tests utilised at this age include red reflex testing and retinal examination, although this 
should be conducted everywhere, the retinal examination is not performed in all areas. 
5.2 Vision screening - Birth to 3 months 
Well, healthy babies, up to the age of 3 months, are screened once by a neonatologist in a 
hospital in every region of Bulgaria. The only test utilised at this age is red reflex testing. It is 
not known how many abnormal or how many inconclusive tests necessitate referral to an 
ophthalmologist for further examination. 
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months do not receive any vision screening.  
5.4 Vision screening - 36 months to 7 years 
Children aged from 36 months to 7 years are screened by a GP in the GPs office. The only 
test utilised at this age is a visual acuity measurement. Referral for further diagnostic 
examination occurs after one abnormal test result. There is no defined policy for the 
number of inconclusive results, for example, due to poor cooperation, before referral for 
further diagnostic examination. There are no specific referral criteria, referral is at the 
discretion of the GP. The optotype charts used include numbers and Tumbling E, most of 
which are linear, crowded tests (it is not known if this is logMAR or Snellen format). It is not 
known at what age visual acuity is measured for the first time, or if it is measured again at 
any other age. 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Neonatologist Ophthalmologist GP 
Preterm babies  × 
9 
Only in available in Sofia and 
Plovdiv 
× 
0 to 3 months  9 × × 
3 to 36 months  × × × 
3 to 7 years  × × 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 Hospital GP clinic Public place Other 
Preterm babies  9 × × × 
0 to 3 months  9 × × × 
3 to 36 months  × × × × 
3 to 7 years  × 9 × × 
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Table 3: Location of vision screening for each age group  
Table 3 
 
Red reflex testing Retinal examination VA measurement 
Preterm babies  9 9 
Not conducted in all areas 
× 
0 to 3 months  9 × × 
3 to 36 months  × × × 
3 to 7 years  × × 9 
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6. Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used 
to detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. No 
automated vision screening is used in Bulgaria.  
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7. Provision for Visually Impaired  
The Association of the Blind in Bulgaria report that there are two schools for blind or 
severely visually impaired children in Bulgaria; it is not known how many children attend 
these schools. There is no special support provided for visually impaired children who 
attend regular primary school.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
A cross-sectional study (Dikova, Dragoev and Chernodrinska, 2018) of 1675 children in 
western Bulgaria, aged between 4 and 10 years showed that the prevalence of treated or 
untreated amblyopia in Bulgaria by the age of 7 years is estimated to be 2.5%. However, due 
to there being no standardised screening in Bulgaria, it is not possible to determine the 
prevalence of persistent amblyopia. There is no data available concerning the prevalence of 
strabismus in Bulgaria. The cross-sectional study also showed that the incidence of the four 
types of amblyopia were: 7% strabismic; 59% anisometropic, 31% isoametropic and 3% 
deprivation. Unilateral amblyopia was diagnosed in 73% of the cases and bilateral 
amblyopia was diagnosed in 27% of the cases. For 45% of the children, it was their first visit 
to an ophthalmologist. 
8.2 Coverage 
The percentage of children invited for vision screening is not available. Invitations for 
general preventative child healthcare screening are made by the GP and is carried out 
during routine visits. It is estimated that approximately 45% of children receive vision 
screening before the age of 7 years (Dikova, Dragoev and Chernodrinska, 2015). The 
assessment of visual acuity as part of vision screening, before the age of 7 years, is 
estimated to be offered to 20% of children with just 40% of these actually attend (Dikova, 
Dragoev and Chernodrinska, 2015).  
8.3 Screening evaluation 
There is not data available concerning the percentage of false negative referrals, false 
positive referrals, the positive predictive value of a refer result, the sensitivity of vision 
screening, or the specificity of vision screening in Bulgaria.  
8.4 Treatment success 
Children who fail vision screening are referred to an ophthalmologist, who are the only 
professionals that prescribe glasses for children under the age of 7 years in Bulgaria. Other 
treatment options include patching, atropine and cataract surgery where required. Not all 
children identified are treated due to the cost, as vision screening is funded through 
charities and parents. There are also compliance problems. There is no information 
concerning the percentage of compliance with referral after an abnormal screening test 
result as there is no registration or documentation of noncompliance.  
Approximately 1% of infants are treated for congenital eye disorders in the total population. 
There is no available data concerning the percentage of children treated for strabismus, or 
amblyopia before the age of 7 years.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
There is no data available concerning the salary costs per year, or per hour, for vision 
screening professionals. It is not known how much it costs to train general preventative 
child healthcare screening professional, between leaving secondary education and 
qualification. The total screening costs per year, or per child per year, for vision screening in 
Bulgaria are not known.  
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients, with refractive amblyopia and 
strabismic amblyopia including follow up are estimated at:  
x 250 Leva (127.82 Euros*) for glasses 
x 20 Leva (10.23 Euros*) per visit, with between 6 and 12 visits required 
x 200 Leva (102.27 Euros*) for patching. 
9.3 Cost of Treatment for strabismus  
 The estimated costs for strabismus surgery including follow up are estimated at:  
x 20 Leva (10.23 Euros*) for each visit  ? of which 12 are needed 
x 1000 Leva (511.35 Euros*) for surgery.  
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery, including follow up of deprivation 
amblyopia, is estimated at:  
x Surgery: 1500 Leva (766.96 Euros*) if an intraocular lens is implanted; 500 Leva 
(255.68 Euros*) if only surgery is needed 
x 300 Leva (153.41 Euros*) for glasses/soft contact lenses 
x 20 Leva (10.23 Euros*) for each visit by an ophthalmologist (at least 10 needed) 
x 300 Leva (153.41 Euros*) for patching. 
There is not financial reward for parents when children attend vision screening, no penalty 
when they do not attend and vision screening is not obligatory for parents and children.  
 
 
 
*Currency conversions are as of 04/10/2018.  
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